Searched for
CONCORD BIOTECH UPDATE
CleanMax Rs 1,500 crore pre-IPO round draws Temasek, Bain CapitalCleanMax Enviro Energy Solutions has secured Rs 1,500 crore in a pre-IPO funding round. Global investors like Temasek and Bain Capital led ...- Stock Radar: 50% rally in 1 year; wait for confirmation of rounding bottom pattern to go long in Concord BiotechConcord Biotech Ltd's stock, after reaching record highs, is poised for a breakout from a Rounding Bottom pattern. Experts suggest a close ...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Concord Biotech to list on Friday. Here’s what GMP suggestsAnalysts are of the opinion that a market premium of over 15% on the issue price is justified based on the company's business model, which ...
- Concord Biotech IPO share allotment likely today. Here's how you can check statusOn the allotment date, investors get to know about the number of shares allotted to them as against the bids made. They can check the allot...
- Concord Biotech IPO subscribed 58% on Day OneThe non-institutional investors (NII) category was subscribed the most at 1.01 times, followed by retail investors at 72%. The category for...
- Concord Biotech IPO opens. Should you subscribe to the issue?Analysts advised investors to subscribe to Concord Biotech IPO given its complex product portfolio, presence in niche space, strong client ...
- Concord Biotech IPO: GMP indicates strong investors' interest ahead of issue openingAhead of the issue opening, the company's shares commanded a premium of Rs Rs 325 in the unlisted market
- Jhunjhunwala-backed Concord Biotech sets IPO price band at Rs 705-741According to the draft papers, Concord Biotech's IPO is entirely an offer for sale of (OFS) of 2,09,25,652 equity shares by Helix Investmen...
- Concord Biotech, Vaibhav Gems get Sebi's approval to float IPOsThe company is backed by Quadria Capital Fund and Rare Enterprises, which was set up by billionaire investor Rakesh Jhunjhunwala, along wit...
Load More
